NZ332565A - Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof - Google Patents

Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof

Info

Publication number
NZ332565A
NZ332565A NZ332565A NZ33256597A NZ332565A NZ 332565 A NZ332565 A NZ 332565A NZ 332565 A NZ332565 A NZ 332565A NZ 33256597 A NZ33256597 A NZ 33256597A NZ 332565 A NZ332565 A NZ 332565A
Authority
NZ
New Zealand
Prior art keywords
vaccine compositions
helicobacter pylori
amino acid
nucleic acid
acid sequences
Prior art date
Application number
NZ332565A
Other languages
English (en)
Inventor
Douglas Smith
Richard A Alm
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NZ332565A publication Critical patent/NZ332565A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NZ332565A 1996-03-29 1997-03-27 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof NZ332565A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US62581196A 1996-03-29 1996-03-29
US75873196A 1996-04-02 1996-04-02
US73690596A 1996-10-25 1996-10-25
US73885996A 1996-10-28 1996-10-28
US76131896A 1996-12-06 1996-12-06
PCT/US1997/005223 WO1997037044A1 (en) 1996-03-29 1997-03-27 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof

Publications (1)

Publication Number Publication Date
NZ332565A true NZ332565A (en) 2000-03-27

Family

ID=27542009

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ332565A NZ332565A (en) 1996-03-29 1997-03-27 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof

Country Status (18)

Country Link
EP (1) EP0901530A1 (id)
JP (1) JP2000501621A (id)
CN (1) CN1220703A (id)
AU (1) AU726892B2 (id)
BR (1) BR9708456A (id)
CA (1) CA2248985A1 (id)
CZ (1) CZ297698A3 (id)
EE (1) EE9800334A (id)
HU (1) HUP0100267A3 (id)
ID (1) ID18542A (id)
IL (1) IL125808A0 (id)
IS (1) IS4831A (id)
NO (1) NO984517L (id)
NZ (1) NZ332565A (id)
PL (1) PL329045A1 (id)
SK (1) SK130598A3 (id)
TR (1) TR199801939T2 (id)
WO (1) WO1997037044A1 (id)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4368944B2 (ja) * 1995-04-21 2009-11-18 シーエスエル、リミテッド 防御用ヘリコバクター抗原
AU735391B2 (en) * 1996-11-14 2001-07-05 Human Genome Sciences, Inc. Helicobacter polypeptides and corresponding polynucleotide molecules
SE9702240D0 (sv) * 1997-06-12 1997-06-12 Astra Ab Vaccine compositions III
EP2261346A3 (en) 1998-05-01 2012-01-04 Novartis Vaccines and Diagnostics, Inc. Neisseria meningitidis antigens and compositions
AU4718999A (en) * 1998-06-26 2000-01-17 American Cyanamid Company Novel antigens of (helicobacter pylori)
DE19847628C2 (de) * 1998-10-15 2000-10-19 Chiron Behring Gmbh & Co Helicobacter pylori-Impfstoff
GB9825184D0 (en) * 1998-11-17 1999-01-13 Cortecs Uk Ltd Antigen
WO2000066722A1 (en) 1999-04-30 2000-11-09 Hybrigenics S.A. Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
SE0001988D0 (sv) * 2000-05-29 2000-05-29 A & Science Invest Ab Novel polypeptides and use thereof
WO2002040516A2 (de) * 2000-11-15 2002-05-23 Ludwig Deml DAS HELICOBACTER CYSTEIN RICH PROTEIN A (HcpA) UND SEINE ANWENDUNGEN
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
TW200303919A (en) * 2001-12-05 2003-09-16 Hiroyuki Ohno Cytotoxic protein and the use
WO2017102779A1 (en) * 2015-12-14 2017-06-22 Technische Universität München Helicobacter pylori vaccines
CN106868024B (zh) * 2017-04-01 2020-03-17 山东新创生物科技有限公司 一种戈氏梭菌特异性pcr检测引物及方法
CN115991745A (zh) * 2022-07-19 2023-04-21 四川大学华西医院 一种幽门螺杆菌重组抗原蛋白TatB及其制备方法与应用

Also Published As

Publication number Publication date
IS4831A (is) 1998-08-21
HUP0100267A3 (en) 2002-09-30
AU2598497A (en) 1997-10-22
NO984517D0 (no) 1998-09-28
IL125808A0 (en) 1999-04-11
HUP0100267A2 (hu) 2001-06-28
WO1997037044A1 (en) 1997-10-09
SK130598A3 (en) 1999-06-11
JP2000501621A (ja) 2000-02-15
TR199801939T2 (xx) 1999-02-22
PL329045A1 (en) 1999-03-01
BR9708456A (pt) 1999-08-03
NO984517L (no) 1998-11-25
EE9800334A (et) 1999-04-15
CN1220703A (zh) 1999-06-23
CA2248985A1 (en) 1997-10-09
ID18542A (id) 1998-04-16
EP0901530A1 (en) 1999-03-17
AU726892B2 (en) 2000-11-23
CZ297698A3 (cs) 1999-02-17

Similar Documents

Publication Publication Date Title
NZ332565A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
DE3590648T1 (id)
WO1998004702A3 (en) Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use
NO991995L (no) Nukleinsyre- og aminosyresekvenser relatert til Heliobacter pylori og vaksinesammensetninger derav
DE69737413D1 (en) Bakterioferritin aus helicobacter pylori
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
HK1046648B (zh) 包括最少兩個不同變應原蛋白的含雜種多肽疫苗
ZA863848B (en) Novel thf compositions
EP0317279A3 (en) Peptides for use in the purification of factor viii
MX9709846A (es) Secuencias de acidos nucleico y aminoacidos relacionados con el helicobacter pylori para procedimientos de diagnostico y terapeuticos.
SE9901548D0 (sv) Helicobacter pylori antigens
ZA979672B (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine composition thereof
TR199701538T1 (xx) Helibakter pilor'un n�kleik asit ve amino asit sekanslar�.
ZA9710971B (en) Nucleic acid and amino acid sequences relating to Helicobacter pylori and vaccine compositions thereof.
ZA972715B (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof.
HUP0000521A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
HUP9903843A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof